Abstract
Foot infections, being one of the major complications, account for nearly 15% of people with diabetes, and increase their risk for amputation in lower extremities. Though various factors contribute to the development of diabetic foot infection, poor glycemic control poses a greater risk paving the way for a number of micro-organisms to colonize the wound.
In order to restore the lost granulation tissue at the ulcer site, the prime aim should not only be attaining glycemic control but also must focus on performing culture by clinically differentiating the stage of infection as well as to manage or control the infection by selecting a rational empiric antibiotic regimen, amidst the uncertainty that exists in choosing best antimicrobial therapy in emerging multi-drug resistance worldwide. This review mainly analyzes that although among the existence of various undefined microbiome being prevalent in causing diabetic foot infections, how the current trend of antibiotics in use aids in treating foot infections in diabetes.Keywords: Diabetic foot infections, matrix metallo-proteinases, wagner classification, methicillin resistant Staphylococcusaureus, antimicrobial therapy, microbiome.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:A Review on the Current Principles of Antibiotic Therapy for Diabetic Foot Infection
Volume: 21 Issue: 5
Author(s): Sainath Prasanna Bharathi and Sathesh Kumar Sukumaran*
Affiliation:
- School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai 600117, Tamilnadu,India
Keywords: Diabetic foot infections, matrix metallo-proteinases, wagner classification, methicillin resistant Staphylococcusaureus, antimicrobial therapy, microbiome.
Abstract:
Foot infections, being one of the major complications, account for nearly 15% of people with diabetes, and increase their risk for amputation in lower extremities. Though various factors contribute to the development of diabetic foot infection, poor glycemic control poses a greater risk paving the way for a number of micro-organisms to colonize the wound.
In order to restore the lost granulation tissue at the ulcer site, the prime aim should not only be attaining glycemic control but also must focus on performing culture by clinically differentiating the stage of infection as well as to manage or control the infection by selecting a rational empiric antibiotic regimen, amidst the uncertainty that exists in choosing best antimicrobial therapy in emerging multi-drug resistance worldwide. This review mainly analyzes that although among the existence of various undefined microbiome being prevalent in causing diabetic foot infections, how the current trend of antibiotics in use aids in treating foot infections in diabetes.Export Options
About this article
Cite this article as:
Bharathi Prasanna Sainath and Sukumaran Kumar Sathesh *, A Review on the Current Principles of Antibiotic Therapy for Diabetic Foot Infection, Infectious Disorders - Drug Targets 2021; 21 (5) : e270421188440 . https://dx.doi.org/10.2174/1871526520999201126203738
DOI https://dx.doi.org/10.2174/1871526520999201126203738 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation and Function of Rankl in Arterial Calcification
Current Pharmaceutical Design Hypertension and Concurrent Arrhythmias
Current Pharmaceutical Design Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Lipid Management for the Prevention of Cardiovascular Disease
Current Pharmaceutical Design Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Acute Phase Treatment of Pulmonary Embolism
Current Vascular Pharmacology Brain SPECT with Perfusion Radiopharmaceuticals and Dopaminergic System Radiocompounds in Dementia Disorders
Current Alzheimer Research Molecular Targets for Promoting Wound Healing in Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) P2X Receptors and Diabetes
Current Medicinal Chemistry Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update
Current Drug Metabolism Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Fluoxetine Metabolism and Pharmacological Interactions: The Role of Cytochrome P450
Current Drug Metabolism Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective
Current Gene Therapy Prevalence, Severity and Characteristics of Tardive Dyskinesia Among Schizophrenia Patients in an Israeli Psychiatric Center
Current Psychopharmacology Purinergic Signalling and Endothelium
Current Vascular Pharmacology Medical Treatment of Hirsutism in Women
Current Medicinal Chemistry Late Effects in Survivors of Childhood CNS Tumors: Review of Results From the Two Largest Survivorship Cooperative Groups
Current Cancer Therapy Reviews Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition
Current Drug Targets